Connect with us

Technology

Seegene and Springer Nature Launch ‘Nature Awards MDx Impact Grants’ to Innovate Syndromic PCR Diagnostic Assays

Published

on

–  Nature Awards MDx Impact Grants in partnership with Seegene extends commitment to external innovation.
–  Global research teams invited to submit proposals to develop new tests for human infectious diseases. Application deadline: December 2, 2024.
–  Nature Awards to lead the application and evaluation process. Projects selected in August 2025 based on clinical need.
–  A major investment in open innovation, the commercialization of multiplex PCR technology and availability of diagnostic tests.

SEOUL, South Korea, Sept. 2, 2024 /PRNewswire/ — Seegene Inc. (KQ096530), a leading South Korean company providing a total solution for PCR molecular diagnostics, announced today an extension of its strategic partnership with Springer Nature, a trusted provider to the global scientific community and the publisher of the prestigious scientific journal, Nature. 

Together, Seegene and Springer Nature launched ‘Nature Awards MDx Impact Grants in partnership with Seegene’, a new project for the development of diagnostic assays. The program empowers researchers worldwide to develop innovative diagnostic assays using Seegene’s advanced multiplex PCR technology.

The global call for proposals builds on the success of the 2023 Open Innovation Program, which attracted 281 applications from 47 countries, with 26 submissions selected. With the launch of the second phase, Seegene and Springer Nature are setting the stage for even broader participation and innovation, furthering their commitment to democratizing molecular diagnostics.

This year’s call invites scientists across the globe to directly propose product development ideas. Researchers are required to submit proposals featuring qualitative PCR-based analysis targeting human infectious diseases.

Selected final awardees will receive significant support, including research funding of up to USD 600,000 per project, as well as Seegene’s provision of syndromic PCR assays, extraction assays, consumables, instruments, and relevant software necessary for their clinical research project.

The application deadline is December 2, 2024. The first evaluation will conclude in February 2025, followed by on-site evaluation and final deliberation. The final awardees will be announced in August 2025 with Nature Awards leading the submission and evaluation process. Seegene will manage overall program planning and onsite evaluations.

“We are thrilled to embark on this new phase with Springer Nature. The new programme reflects the strong global interest generated by last year’s initiative.” said Dr. Jik Young Park, Vice President and Head of Seegene’s R&D Division. “We are committed to driving the development and commercialization of innovative syndromic PCR products that will originate from the visionary minds in the global research community.”

“By allowing scientists to directly propose their ideas for product development, we anticipate expanding the range of innovation and ensuring that projects meet unmet clinical needs.” said Marc Spenlé, Chief Operating Officer of Springer Nature. “Springer Nature will leverage its extensive network in the scientific community to foster robust participation and ensure the success of this collaborative program.”

The Nature Awards MDx Impact Grants in Partnership with Seegene aim to accelerate open innovation and advance the commercialization of molecular diagnostics solutions for unmet clinical needs. Through this award program, Seegene and Springer Nature seek to shape a future where timely and accurate diagnoses help create a framework to create “Funds and tech to amplify PCR for a healthier world”.

About Seegene 

Seegene has 23 years of dedicated experience in R&D, manufacturing, and business related to multiplex PCR technologies. This expertise was particularly highlighted during the COVID-19 pandemic when Seegene provided over 340 million COVID-19 tests to more than 100 countries worldwide. The core feature of Seegene’s multiplex PCR technology is the ability to simultaneously test for 14 pathogens that cause similar symptoms in a single tube and provide quantitative information on the infection profile to correlate with the progression of illness.

Visit: Seegene.com and follow linkedin.com/company/seegene-inc

About Nature Awards

The Nature Awards is a global awards programme focused on driving the goals and values that matter most to research and wider communities: research excellence, integrity and transparency, impact, inclusivity, engagement, sustainability, and the importance of evidence in public life. Its diverse range of programmes recognise, reward, connect and celebrate researchers from all over the world who share its values and chase those goals. For more information on all Nature Awards programmes, please visit Nature Awards website.

About Springer Nature

Springer Nature opens the doors to discovery for researchers, educators, clinicians and other professionals. Every day, around the globe, Springer Nature’s imprints, books, journals, platforms and technology solutions reach millions of people. For over 180 years its brands and imprints have been a trusted source of knowledge to these communities and today, more than ever, Springer Nature sees it as responsibility to ensure that fundamental knowledge can be found, verified, understood and used by Springer Nature’s communities – enabling them to improve outcomes, make progress, and benefit the generations that follow.

Visit: springernature.com/gp/group and follow @SpringerNature.

Photo – https://mma.prnewswire.com/media/2494234/Homepage__Nature_Awards_MDx_Impact_Grants__website_a_global_open.jpg
Logo – https://mma.prnewswire.com/media/1357790/Seegene_logo_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/seegene-and-springer-nature-launch-nature-awards-mdx-impact-grants-to-innovate-syndromic-pcr-diagnostic-assays-302235984.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Redefining the Standard of Care: Introducing the Aulisa® Monitor Camera for Advanced Patient Monitoring

Published

on

By

PALO ALTO, Calif., Nov. 22, 2024 /PRNewswire/ — Aulisa® Medical USA, Inc., a leader in FDA-cleared, wearable, wireless continuous vital sign monitoring technology, proudly announces the launch of the Aulisa® Monitor Camera, an innovative solution designed to revolutionize patient care in both hospital and home settings. Seamlessly integrating with the Aulisa® Vital Signs Monitoring System, this advanced camera offers caregivers and healthcare professionals enhanced monitoring capabilities and peace of mind.

Redefining the Standard of Care
Hospitals constantly balance delivering exceptional patient care with managing operational costs. The Aulisa® Monitor Camera redefines patient monitoring by providing advanced, centralized solutions that enhance clinical and operational excellence. Designed to optimize patient care, the Aulisa® Monitor Camera integrates with the Centralized Multiple Patient Monitoring (CMPM) System, enabling simultaneous, wireless monitoring of oxygen saturation (SpO2), pulse rate, and body temperature across multiple patients from a centralized nursing station. With a simple app, the Aulisa® Monitor Camera can be integrated into a CMPM. In addition to monitoring a patient’s vital signs, caregivers and family members (such as parents of an infant) can also view the patient’s image and hear their voice. This feature is especially important in specific situations, such as for parents of an infant in the NICU.

This transformative approach eliminates cumbersome wires, streamlines operations, and ensures timely interventions, ultimately improving patient outcomes, enhancing safety standards, and optimizing workflow efficiency while driving significant cost savings and financial performance for healthcare facilities. With a steadfast commitment to compassionate, data-driven care and innovative solutions, Aulisa® Medical is advancing patient health and redefining healthcare excellence, one patient at a time.

Advanced Features for Comprehensive Care
The Aulisa® Monitor Camera offers crystal-clear 2K resolution with night vision, ensuring high-quality visuals day and night. Its two-way audio and human tracking features enable real-time communication and automated movement monitoring, while effortless Wi-Fi integration allows for quick and simple setup via mobile or web devices. With dual functionality as a standalone home surveillance camera, the Aulisa® Monitor Camera delivers unmatched flexibility for various care scenarios.

Engineered for Hospital Excellence
Designed with hospitals and patients in mind, the Aulisa® Monitor Camera addresses the unique demands of modern healthcare settings. From NICUs to patient rooms, it offers caregivers the ability to remotely monitor patients with visual, audio, and motion tracking capabilities. This streamlines workflows, enhances safety, and allows providers to focus on delivering compassionate care while staying equipped with FDA-cleared technology.

Founder’s Vision
“Introducing the Aulisa® Monitor Camera is a natural extension of our mission to enhance patient care and empower healthcare professionals,” said Augustine (Augie) Lien, founder and CEO of Aulisa Medical USA, Inc. “We strive to provide innovative solutions that bring peace of mind to caregivers and families alike. By delivering FDA-cleared technology with seamless functionality, we’re making it easier to ensure safety, connectivity, and exceptional care in every setting.”

Why Choose Aulisa®?
The Aulisa® Monitor Camera enhances efficiency by enabling remote monitoring, reducing physical check-ins, and providing reliable, FDA-cleared technology trusted by healthcare professionals worldwide. It is now available for purchase by healthcare facilities, caregivers, and families.

To learn more about the Aulisa Monitor Camera, the Guardian Angel® CMPM System and other Aulisa Medical products, visit:

www.aulisa.com/products/aulisa-monitor-camerawww.aulisa.com/products/cmpmwww.aulisa.com/collections/guardian-angel-remote-gateway-systems

About Aulisa Medical
Based in Silicon Valley, Aulisa® Medical is a leading medical technology company founded by serial medical technologies entrepreneur, Augustine (Augie) Lien. The company specializes in developing wireless, wearable monitoring systems that provide continuous, cloud-based vital sign data in both clinical and home environments. Through the development of new healthcare innovations, Aulisa® continues to grow the application of digital health technologies that empower both consumers and healthcare providers, incorporating Artificial Intelligence (AI) technologies that can detect adverse events and potentially save lives.

Media Contact:
Kyle Thompson, Vice President of Sales & Marketing
Email: kyle.thompson@aulisa.com
Direct: (650) 387-0001
www.aulisa.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/redefining-the-standard-of-care-introducing-the-aulisa-monitor-camera-for-advanced-patient-monitoring-302314670.html

SOURCE Aulisa Medical USA, Inc.

Continue Reading

Technology

Redefining Financial Frontiers: Nucleus Software Celebrates 30 Years with Synapse 2024 in Singapore

Published

on

By

SINGAPORE, Nov. 23, 2024 /PRNewswire/ — The thriving IndiaSingapore partnership in banking and technology reached a new milestone as Nucleus Software celebrated 30 years of transformative innovation at Synapse 2024, held in Singapore. The event underscored the company’s role in redefining financial services across Southeast Asia (SEA) and the globe, bringing together leaders in finance and technology to explore a shared vision for the future of banking.

Synapse 2024 celebrated 30 years of Nucleus Software’s leadership in driving transformative change across Singapore and Southeast Asia’s financial ecosystem. The event also shone a spotlight on the Global Finance & Technology Network (GFTN), an initiative supported by the Monetary Authority of Singapore (MAS) to champion responsible technology adoption. The event highlighted the deepening synergies between India and Singapore, driven by their shared commitment to innovation, cross-border collaboration, and financial inclusion. As the financial services sector undergoes rapid evolution with advancements in artificial intelligence, blockchain, and digital banking, these partnerships are setting the stage for a more connected, resilient, and inclusive global ecosystem.

Vishnu R. Dusad, Co-founder and Managing Director of Nucleus Software, reflected on the milestone: “For over 30 years, we’ve had the privilege of aligning our journey with Singapore’s ascent as a global financial powerhouse. Back in 1994, when we chose to go East instead of West, it was a bold and emotional decision—guided by our belief in Singapore as a hub for innovation and collaboration. We saw then what remains true today: Singapore is at the heart of the global financial landscape, a place where new ideas take root, and partnerships thrive.”

The event brought together a distinguished array of participants, highlighting the transformative potential of IndiaSingapore collaboration. Mr. Piyush Gupta, CEO of DBS Group and the Guest of Honor, set the tone for the event with his opening remarks, emphasizing the transformative role of big tech in reimagining scalable, customer-centric financial services in the digital age.

Following his address, key speakers enriched the discussions with their insights. Mr. Sopnendu Mohanty, Chief Fintech Officer at the Monetary Authority of Singapore and Group CEO-Designate of The Global Finance & Technology Network (GFTN), underlined the importance of fostering responsible technology adoption and building inclusive financial ecosystems. Mr. Vinod Rai, globally respected public policy expert, Distinguished Visiting Research Fellow at the National University of Singapore, and former Comptroller and Auditor General of India, shared his perspectives on governance and policy frameworks in financial systems. Mr. S.M. Acharya, Chairman of Nucleus Software and former Defence Secretary of India, offered a visionary outlook on leveraging technology to modernize and secure banking frameworks. Finally, Mr. Pieter Franken, Co-founder and Director of GFTN (Japan), a global FinTech pioneer and deep tech innovator, discussed the future of decentralized finance and its implications for the financial sector.

The event showcased the transformative role of technology in global financial systems, emphasizing innovations that set benchmarks for scalability and inclusivity. Panelists discussed the importance of localized solutions, the challenges of cross-border integration, and leveraging dual business models to optimize capital and foster public participation. The dialogue highlighted the need for common standards, unified frameworks like APIs, and collaborative efforts to accelerate financial inclusion and drive global connectivity in the digital age.

For 30 years, Nucleus Software has consistently introduced advanced lending and banking solutions that support financial institutions’ evolving needs in Singapore and South East Asia. Driven by lean development methodologies like Acceptance Test-Driven Development (ATDD) and Continuous Integration/Continuous Delivery (CICD), Nucleus Software continues to push boundaries in efficient, flexible, and secure financial technology.

Photo: https://mma.prnewswire.com/media/2565374/Synapse_2024.jpg
Logo: https://mma.prnewswire.com/media/2565373/Nucleus_Software_Logo.jpg

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/redefining-financial-frontiers-nucleus-software-celebrates-30-years-with-synapse-2024-in-singapore-302314485.html

Continue Reading

Technology

Sleighing the Digital Divide with Black Friday Tech Deals

Published

on

By

Holiday Mix & Match Deal puts tech and accessories under your tree for $200 or less!

DETROIT, Nov. 22, 2024 /PRNewswire/ — This holiday season, Human-I-T, a nonprofit dedicated to providing equitable access to technology, is making it easier than ever for holiday shoppers to access affordable tech while giving back to their community. The “Mix and Match Deal,” allows individuals to purchase devices and accessories at prices that fit any budget—all while supporting efforts to close the digital divide.

“For the past 12 years, Human-I-T has been laser-focused on three things: making technology accessible and affordable, offering digital navigation support to those who need it most, and saving our planet by keeping e-waste out of landfills,” said Graeme Jackson, Marketing and Content Manager at Human-I-T. “The ‘Holiday Mix & Match Deal’ helps us achieve all three goals, and the best part is that everyone benefits.”

Available from Friday, November 29th, through Monday, December 30th, the deal offers customers the chance to bundle one device—a tablet, Chromebook, or 2-in-1 device—with one accessory of their choice, including JBL speakers, headphones, a protective laptop sleeve, or a wireless keyboard for $200 or less.

For families, students, or job seekers who may struggle to afford essential technology, this initiative is more than a sale—it’s a lifeline. Human-I-T believes that in today’s digital world, access to reliable technology isn’t a luxury; it’s a basic human right.

“This isn’t just about shopping,” added Jackson. “It’s about providing hope, opportunity, and connection to those who need it most. When you shop with us, you’re not only getting a great deal—you’re helping to change lives.”

The Mix & Match Deal is only available for a limited time. By shopping at Human-I-T’s online store customers can brighten their holiday while directly supporting underserved communities.

Don’t wait—login to the Human-I-T store today

and give the gift of technology that gives back!

View original content to download multimedia:https://www.prnewswire.com/news-releases/sleighing-the-digital-divide-with-black-friday-tech-deals-302314632.html

SOURCE Human-I-T

Continue Reading

Trending